Carcinoma in situ of lip, oral cavity and pharynx
- D00.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM D00.0 became effective on October 1, 2024.
- This is the American ICD-10-CM version of D00.0 – other international versions of ICD-10 D00.0 may differ.
Use Additional
- code to identify:
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
Type 1 Excludes
- carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
- carcinoma in situ of epiglottis NOS (D02.0)
- carcinoma in situ of epiglottis suprahyoid portion (D02.0)
- carcinoma in situ of skin of lip (D03.0, D04.0)
The following code(s) above D00.0 contain annotation back-references
that may be applicable to D00.0:
- C00-D49 Neoplasms
- D00-D09 In situ neoplasms
- D00 Carcinoma in situ of oral cavity, esophagus and stomach
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to D00.0:
- Type 1 Excludes: K13.2